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The potential health effects of meal and oil processed from seed of genetically modiﬁed (GM) canola
plants (OECD unique identiﬁer: DP-Ø73496-4; hereafter referred to as 73496 canola) containing an insert
that expresses the GAT4621 protein conferring tolerance to nonselective herbicidal ingredient glyphosate
were evaluated in a subchronic rodent feeding study. Sprague–Dawley rats (12/sex/group) were admin-
istered diets containing dehulled, defatted toasted canola meal (DH meal) and reﬁned/bleached/deodor-
ized canola oil (RBD oil) processed from seed of plants that were untreated (73496), sprayed in-ﬁeld with
glyphosate (73496GLY), the non-transgenic near-isogenic (091; control), or one of four commercially
available non-GM reference canola varieties (45H72, 45H73, 46A65, 44A89). All diets were formulated
as a modiﬁcation of the standard laboratory chow PMI Nutrition International, LLC Certiﬁed Rodent Lab-
Diet 5002 (PMI 5002). DH canola meal and RBD canola oil replaced all commodity soybean fractions
typically incorporated in PMI 5002. No toxicologically signiﬁcant differences were observed between
the test and control groups in this study. The results reported herein support the conclusion that DH meal
and RBD oil processed from seed of 73496 canola are as safe and nutritious as DH meal and RBD oil pro-
cessed from seed of non-GM canola.
 2014 The Authors. Published by Elsevier Ltd. Open access under CC BY license.1. Introduction
The ﬁeld of agricultural biotechnology has been developing rap-
idly over the past 20 years to expand the introduction of traits
including herbicide tolerance into ﬁeld crops. This has been accom-
plished by plant transformation with DNA constructs that drive
expression of transgenic proteins with a narrow spectrum of activ-
ity that the native plant typically does not possess (De Block et al.,
1987). One of the most widely distributed genetically modiﬁed
(GM) plant is Roundup Ready soybeans that are tolerant to the
non-selective herbicidal active ingredient glyphosate. All plants
express an endogenous 5-enolpyruvylshikimate-3-phosphate syn-
thase (EPSPS) enzyme that is required for biosynthesis of aromatic
amino acids (Padgette et al., 1995). The native EPSPS enzyme in
soybeans and other ﬁeld crops is sensitive to inhibition by glyphos-
ate; hence treatment of plants with glyphosate will cause phyto-
toxicity. Roundup Ready soybeans, however, were modiﬁed toexpress a form of the EPSPS protein from Agrobacterium strain
CP4 that is not sensitive to inhibition by glyphosate (Padgette
et al., 1995 and Funke et al., 2006). Therefore, the GM plants in
which the CP4 EPSPS protein is expressed have a selective advan-
tage over weeds in ﬁelds when glyphosate is applied.
While the CP4 EPSPS protein has been widely implemented in
soybeans and other crops, it is not the only method for conferring
tolerance to glyphosate. The glyphosate acetyltransferase (GAT)
protein obtained from Bacillus licheniformis detoxiﬁes glyphosate
via acetylation (Castle et al., 2004). This protein was optimized
for this enzymatic reaction by multiple rounds of gene shufﬂing
that increased the acetylation activity by 5000–10,000-fold com-
pared with the native enzyme (Castle et al., 2004; Siehl et al.,
2005, 2007). Expression of this enzyme in GM crops confers toler-
ance to glyphosate. Two different variants of the GAT protein have
been developed, GAT4601 and GAT4621. The GAT4601 protein has
been expressed in soybean crops while the GAT4621 protein has
been used in maize. Both proteins have been subjected to extensive
safety testing and represent no risk for allergenicity or toxicity
(GAT4601 data in Delaney et al., 2008b; GAT4621, unpublished
results).
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of canola (Brassica napus) to produce event DP-Ø73496-4 (hereaf-
ter referred to as 73496). Though the safety of the GAT4621 protein
was assessed separately, the current study was conducted to deter-
mine whether the process of this transformation resulted in unin-
tentional changes that could result in adverse effects as has been
conducted for other crops developed with biotechnology including
corn and soybeans. In the current study, dehulled/defatted toasted
meal (DH meal) and reﬁned/bleached/deodorized oil (RBD oil) pro-
cessed from seed of 73496 canola (untreated or treated in-ﬁeld
with glyphosate herbicide [73496GLY]) were formulated into ro-
dent diets conforming to commercial speciﬁcations for PMI Nutri-
tion International, LLC Certiﬁed Rodent LabDiet 5002 (PMI 5002)
by replacement of all commodity soybean fractions typically used.
For comparison purposes, rodent diets were prepared with DH
meal and RBD oil obtained from the non-transformed near-iso-
genic canola (control 091). Four additional diets incorporated DH
meal and RBD oil from commercially available non-GM canola
varieties (Pioneer brand products 45H72, 45H73, 46A65, and
44A89). The respective diets were fed to groups of young Sprague
Dawley rats for at least 91 days in accordance with OECD Guideline
408 (OECD, 1998) in a comparative study design similar to that re-
ported for GM maize and soybean (Hammond et al., 2004, 2006a,
2006b; MacKenzie et al., 2007; Malley et al., 2007; Appenzeller
et al., 2008; He et al., 2008; Healy et al., 2008). This study was con-
ducted in a facility accredited by the Association for Assessment
and Accreditation of Laboratory Animal Care International (AAA-
LAC). The protocol and study design were reviewed and approved
by the DuPont Haskell Institutional Animal Care and Use Commit-
tee (IACUC).2. Materials and methods
2.1. Canola production, processing, and characterization
Test (73496 and 73496GLY), non-transformed near-isogenic control (091), and
commercially available non-transgenic DuPont Pioneer reference (varieties 45H72,
45H73, 46A65, and 44A89) canola plants were grown under standard ﬁeld condi-
tions. Only 73496GLY canola was treated in-ﬁeld with two applications of glyphos-
ate herbicide (Touchdown HiTech™, [Syngenta]). The 73496 and 73496GLY were
planted approximately 800 m from control and reference canola to prevent contam-
ination from pollen ﬂow (standard plot isolation USDA requirement for canola is
201 meters [USDA, 2013]). Additionally, PCR analysis for presence of event DP-
Ø73496-4 was conducted on the seed collected from the test, control, and reference
canola plots to assess purity after harvest (data not shown).
Harvested canola seed from all sources was processed to dehulled/defatted
toasted meal (DH meal) and reﬁned/bleached/deodorized (RBD) oil fractions at
GLP Technologies (GLP Technologies, Navasota, Texas, U.S.A.). Meal and oil were ob-
tained from canola seed that had been partially dehulled (partial or complete re-
moval of the outer shell, husk, hull, seedcoat, etc.) through an impact-dehulling
procedure that utilized a radial fan to ﬁrst crack the seedcoat followed by forced-
air separation of the seedcoat from the kernel. This process achieved an approxi-
mate 50% removal of seedcoat (veriﬁed compositionally; proprietary canola
batch-processing method of GLP Technologies, Navasota, Texas).
The presence of event DP-Ø73496-4 in the test canola meals and its absence
from control and reference meals was conﬁrmed using event-speciﬁc qualitative
PCR analysis (DuPont Pioneer, Ankeny, IA). All meals were evaluated by antibody-
speciﬁc enzyme-linked immunosorbant assay (ELISA) for the presence and concen-
tration of the GAT4621 protein (DuPont Pioneer, Ankeny, IA). The ELISA method was
developed at Pioneer and internally validated for each matrix prior to use and the
LLOQ therefore is sensitive to the limits deﬁned for both the canola meal
(0.22 ng/mg dry weight) and the diets containing the canola meal (0.11 ng/mg
dry weight). DH meal and RBD oil were characterized for composition (nutrients,
anti-nutrients, and contaminants) by EPL Bio Analytical Services (EPL BAS; Niantic,
IL) except where noted otherwise. The following nutrients were quantiﬁed in the
DH canola meals: moisture and dry matter, proximates (ash, crude fat, crude pro-
tein, crude ﬁber, ADF [acid detergent ﬁber], NDF [neutral detergent ﬁber], carbohy-
drate), 18 individual protein amino acids, minerals (Ca, P, Mg, K, Na, Zn, Mn, Cu, Fe),
selenium (Euroﬁns Scientiﬁc Inc., Des Moines, IA), and vitamins (folic acid, niacin,
thiamine, riboﬂavin, pyridoxine, pantothenic acid). A fatty acid proﬁle (30 individ-
ual fatty acids, including erucic acid [C22:1]) and vitamins (individual tocopherols,
vitamin E) were quantiﬁed in the RBD canola oils. The antinutrients sinapine,soluble and insoluble tannins, phytic acid, and 13 individual glucosinolates were
quantiﬁed in the DH meals, and chlorophyll was quantiﬁed in the RBD oils. Chem-
ical contaminants (chlorinated hydrocarbon and organophosphate pesticide and
paraquat and diquat herbicide residues) were analyzed in the DH meals (Columbia
Food Laboratories, Inc., Corbett, OR), and tributylphosphate (TBP; an industrial
chemical used as a hydraulic lubricant; see below) was quantiﬁed in both the meals
and oils (Columbia Food Laboratories, Inc.).
2.2. Diet formulation, manufacture, and administration
All experimental diets were formulated by Purina Mills, LLC (St. Louis, MO) and
prepared in meal form by Purina TestDiet (Richmond, IN) to be isonitrogenous and
isocaloric, with a nutritional proﬁle comparable with PMI Nutrition International,
LLC Certiﬁed Rodent LabDiet 5002. Experimental diets were produced by replace-
ment of all commodity soybean fractions typically incorporated in PMI 5002 with
DH canola meal and RBD canola oil. DH canola meal fully replaced soybean meal on
a protein equivalency basis using the analyzed crude protein content of each test,
control, or reference canola meal; variable amounts of the control, test (73496 or
73496GLY), or reference RBD canola oils were added to balance the fat and energy
provided by the residual oil in the corresponding DH canola meals (see below). All
diets were refrigerated until administration. Fresh diet was supplied weekly, and
animals were fed the experimental diets for at least 91 consecutive days.Canola source and diet description DH Canola meal (%) RBD Canola oil (%)Control 22.6 1.46
73496 20.6 2.02
73496GLY 19.3 1.96
Reference 45H72 23.4 2.06
Reference 45H73 24.3 1.94
Reference 46A65 23.0 1.58
Reference 44A89 21.7 1.642.3. Diet characterization
All diets were analyzed quantitatively for nutrient composition and contami-
nants (Table 1). Analysis of moisture and dry matter, nutritional proximates, pro-
tein amino acids, minerals, and vitamins in the diets was conducted by the same
laboratories identiﬁed in Section 2.l. Quantiﬁcation of b-carotene and gross energy
determination were performed by EPL BAS. Additional vitamins (A [as retinol], B12
[cobalamin], D3 [cholecalciferol], biotin, choline), minerals (Co, Cl, Cr, F, I), and hea-
vy metals (As, Cd, Pb, Hg) were quantiﬁed by Euroﬁns Scientiﬁc Inc. Mycotoxin
analysis included quantiﬁcation of aﬂatoxins B1, B2, G1, and G2, fumonisins B1
and B2, cyclopiazonic acid, moniliformin, T-2 toxin, zearalenone, deoxynivalenol,
3-acetyl-deoxynivalenol, and 15-acetyl-deoxynivalenol (Romer Labs, Inc., Union,
MO) and oosporein, ergosine, ergotamine, ergocornine, ergocryptine, and ergocris-
tine (University of Missouri Veterinary Medical Diagnostic Laboratory, Columbia,
MO). Analysis of pesticide residues and TBP in the diets was conducted by the same
laboratory identiﬁed in Section 2.1.
Homogeneity of the 73496 and 73496GLY experimental diets and their stability
under relevant ambient conditions of use (1-week) and long-term refrigerated stor-
age (12 weeks) was assessed by quantitative ELISA determination of GAT4621 con-
centration. The ELISA method used to quantify the concentration was developed
and validated at DuPont Pioneer prior to use in this study (data not shown). Addi-
tionally, all experimental diets were analyzed by event-speciﬁc qualitative PCR for
the presence or absence of event DP-Ø73496-4 to verify identity preservation and
lack of detectable cross-contamination.
2.4. Laboratory animals and housing
Male and female Crl:CD(SD [Sprague–Dawley]) rats were obtained from
Charles River Laboratories, Inc., (Raleigh, NC) and housed as described previously
(MacKenzie et al., 2007; Malley et al., 2007; Appenzeller et al., 2008). Rats approx-
imately 6–8 weeks of age were assigned to groups (n = 12/sex/group) following
computerized randomization based on body weight. During the pretest period, ani-
mals were fed PMI Certiﬁed Rodent LabDiet 5002 ad libitum. During the test per-
iod, animals were fed the 091, 73496, 73496GLY, 45H72, 45H73, 46A65, or 44A89
diets ad libitum, except when fasted prior to sacriﬁce when food, but not water,
was withheld for a minimum of 15 h.
2.5. Clinical observations and anatomic pathology
The feeding trial was conducted at DuPont Haskell Global Centers for Health
and Environmental Sciences (DuPont Haskell; Newark, DE), an AAALAC-accredited
facility, in accordance with the OECD 408 guideline for a repeated dose 90-day oral
toxicity study in rodents (OECD, 1998). All animals were observed for mortality or
moribundity twice daily and clinical observations were conducted daily. Body
Table 1
Composition of rodent diets.
091 45H72 45H73 45A65 44A89 73496 73496GLY
Proximates
Moisture (%) 7.89 8.46 8.58 8.76 8.86 8.05 8.26
Dry matter (%) 92.1 91.5 91.4 91.2 91.1 91.9 91.7
Protein (%DB) 22.4 22.1 22.8 22.9 22.2 21.4 22.1
Fat (%DB) 6.18 6.23 5.66 5.38 5.89 6.41 5.97
ADF (%DB) 8.89 9.69 8.90 10.1 9.21 8.36 7.92
Crude ﬁber (%DB) 6.20 5.59 5.98 6.26 5.78 5.75 5.63
NDF (%DB) 17.4 15.9 16.5 16.9 16.5 16.3 16.6
Ash (%DB) 6.34 6.23 6.75 6.36 5.97 5.95 6.15
Carbohydrates (%DB) 65.0 65.4 64.8 65.4 66.0 66.2 65.8
Gross energy content (kcal/100 g DB) 459 467 461 464 468 463 464
Amino acids (%DB)
Ala 1.20 1.15 1.22 1.25 1.22 1.09 1.13
Arg 1.17 1.05 1.18 1.14 1.16 0.964 1.04
Asp 1.85 1.75 1.92 1.96 1.93 1.76 1.76
Cys 0.397 0.415 0.392 0.405 0.475 0.384 0.399
Glu 4.43 4.11 4.57 4.56 4.66 4.04 4.04
Gly 1.15 1.05 1.14 1.18 1.14 0.988 1.05
His 0.601 0.541 0.599 0.594 0.583 0.514 0.534
Ile 0.851 0.783 0.880 0.877 0.868 0.752 0.769
Leu 1.73 1.58 1.77 1.74 1.72 1.53 1.56
Lys 1.31 1.27 1.37 1.39 1.39 1.17 1.19
Met 0.390 0.425 0.404 0.406 0.466 0.378 0.400
Phe 0.960 0.858 0.950 0.939 0.916 0.814 0.843
Pro 1.53 1.42 1.54 1.53 1.54 1.37 1.38
Ser 0.997 0.915 1.01 1.02 0.995 0.875 0.898
Thr 0.873 0.800 0.905 0.899 0.880 0.757 0.781
Trp 0.283 0.271 0.285 0.287 0.301 0.300 0.266
Tyr 0.517 0.471 0.528 0.465 0.495 0.384 0.459
Val 1.09 1.00 1.12 1.12 1.10 0.960 0.983
Minerals
Calcium (%DB) 1.09 1.08 1.04 1.10 1.06 1.01 1.08
Copper (%DB) 0.00185 0.00179 0.00166 0.00129 0.00159 0.00107 0.00104
Iron (%DB) 0.0178 0.0195 0.0341 0.0178 0.0175 0.0173 0.0183
Magnesium (%DB) 0.324 0.316 0.335 0.321 0.304 0.284 0.290
Manganese (%DB) 0.00878 0.00904 0.00893 0.00877 0.00968 0.00831 0.00849
Phosphorus (%DB) 0.867 0.832 0.859 0.862 0.830 0.788 0.837
Potassium (%DB) 1.02 1.06 1.05 0.988 0.969 0.908 0.921
Sodium (%DB) 0.230 0.257 0.449 0.406 0.391 0.370 0.286
Zinc (%DB) 0.009 0.009 0.010 0.009 0.010 0.008 0.009
Selenium (ppm) 0.480 0.440 0.420 0.430 0.480 0.410 0.430
Chloride-soluble (ppm) 5103 5353 5470 5261 5157 5112 5450
Chromium (ppm) 1.4 1.7 2.5 1.9 1.6 1.7 1.6
Cobalt (ppm) 0.90 1.1 1.6 1.2 1.1 1.2 1.2
Fluoride (ppm) <15 <15 <15 <15 <15 <15 <15
Iodine (ppm) 0.387 0.696 2.510 3.920 3.130 3.060 0.924
Vitamins
Beta carotene (IU/100 g DB) 1048 915 836 816 980 970 873
Vitamin B1 (mg/100 g DB) 1.22 1.63 2.03 1.92 1.14 1.05 1.36
Vitamin B2 (mg/100 g DB) 0.398 0.522 0.579 0.814 0.492 0.541 0.459
Folic acid (mg/100 g DB) 0.430 0.463 0.696 0.697 0.464 0.555 0.727
Niacin (mg/100 g DB) 8.21 10.4 7.59 14.5 11.4 5.02 6.88
Pantothenic acid (mg/100 g DB) 1.74 2.07 2.42 2.01 2.01 1.56 1.95
Vitamin B6 (mg/100 g DB) 0.793 0.842 0.756 0.840 0.559 0.732 0.766
Alpha tocopherol (mg/100 g DB) 1.58 1.53 1.28 1.31 1.34 1.47 1.46
Beta tocopherol (mg/100 g DB) 0.285 0.306 0.277 0.269 0.267 0.260 0.280
Delta tocopherol (mg/100 g DB) 0.0756 0.0869 0.0798 0.0949 0.0687 0.0702 0.0620
Gamma tocopherol (mg/100 g DB) 2.32 2.44 2.19 2.49 2.16 2.20 2.19
Tocopherols total (mg/100 g DB) 4.26 4.36 3.83 4.16 3.84 4.00 3.99
Vitamin E as alpha tocopherol (IU/g DB) 0.236 0.228 0.192 0.195 0.201 0.219 0.217
Retinol (IU/100 g DB) 1173 1715 1203 835 1141 1006 1395
Biotin (mg/100 g DB) 0.0744 0.0613 0.0684 0.0609 0.0689 0.0569 0.0690
Vitamin B12 (mg/100 g DB) 0.00785 0.00480 0.00522 0.00589 0.00555 0.00485 0.00552
Vitamin D3 (IU/100 g DB) 225 239 234 242 269 260 247
Choline, total (mg/100 g DB) 197 178 175 182 179 187 190
Mycotoxins
Aﬂatoxin B1 (ppb) <1.0 <1.0 <1.0 <1.0 <1.0 <1.0 <1.0
Aﬂatoxin B2(ppb) <1.0 <1.0 <1.0 <1.0 <1.0 <1.0 <1.0
Aﬂatoxin G1 (ppb) <1.0 <1.0 <1.0 <1.0 <1.0 <1.0 <1.0
Aﬂatoxin G2 (ppb) <1.0 <1.0 <1.0 <1.0 <1.0 <1.0 <1.0
Moniliformin (ppm) <0.4 0.5 <0.4 0.5 0.6 1.4 1.0
Cyclopiazonic Acid (ppm) <0.5 <0.5 <0.5 <0.5 <0.5 <0.5 <0.5
T-2 Toxin (ppm) <0.1 <0.1 <0.1 <0.1 <0.1 <0.1 <0.1
Deoxynivalenol (ppm) 0.2 0.1 0.4 0.1 0.1 0.4 1.0
(continued on next page)
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Table 1 (continued)
091 45H72 45H73 45A65 44A89 73496 73496GLY
15-Acetyl-DON (ppm) <0.1 <0.1 <0.1 <0.1 <0.1 <0.1 <0.1
3-Acetyl-DON (ppm) <0.1 <0.1 <0.1 <0.1 <0.1 <0.1 <0.1
Zearalenone (ppb) <100 <100 <100 <100 <100 <100 <100
Fumonisin B1 (ppm) <0.2 <0.2 <0.2 <0.2 <0.2 <0.2 <0.2
Fumonisin B2 (ppm) <0.2 <0.2 <0.2 <0.2 <0.2 <0.2 <0.2
Oosporein (ppm) Not detected Not detected Not detected Not detected Not detected Not detected Not detected
Ergosine (ppb) 5.0 5.0 25.0 10.0 10.0 5.0 10.0
Ergotamine (ppb) 10.0 10.0 10.0 20.0 20.0 5.0 10.0
Ergocornine (ppb) 20.0 5.0 10.0 5.0 10.0 10.0 5.0
Ergocryptine (ppb) 20.0 10.0 30.0 15.0 10.0 10.0 10.0
Ergocristine (ppb) 25.0 25.0 15.0 15.0 55.0 15.0 30.0
TBP (ppm)
5.0 6.3 0.05 0.53 <0.05 Not analyzed Not analyzed
176 B. Delaney et al. / Food and Chemical Toxicology 66 (2014) 173–184weight and food consumption were determined daily during the ﬁrst week of the
exposure period and weekly thereafter. Food efﬁciency was calculated for the same
intervals from the food consumption and body weight data.
Ophthalmology, neurobehavioral assessments (sensory function observations,
grip strength, and motor activity), hematology, coagulation, clinical chemistry, uri-
nalysis, organ weights and gross pathology were conducted for animals in all
groups as reported previously (MacKenzie et al., 2007; Malley et al., 2007;
Appenzeller et al., 2008), with the addition of total bile acids to the clinical
chemistry proﬁle. Microscopic pathology evaluations were conducted for animals
in the 73496 and 73496GLY test and 091 control groups as reported previously
(MacKenzie et al., 2007; Malley et al., 2007; Appenzeller et al., 2008). Tissues from
rats in the reference groups (45H72, 45H73, 46A65, and 44A89) were not examined
microscopically, except for the male rat in group 44A89 that was sacriﬁced in
extremis on day 50 and thymus tissue from all surviving females. Evaluation of
additional thymus tissue was undertaken to clarify the background incidence of
epithelial hyperplasia in this study.
2.6. Statistical analysis
For all data, the test diet groups (73496 and 73496GLY) were compared sepa-
rately and by gender with the corresponding control diet group (091) to assess
whether differences might correlate with consumption of diets formulated with
processed food and feed fractions from genetically modiﬁed canola. Differences be-
tween values were considered statistically signiﬁcant at p < 0.05. Preliminary tests
to verify homogeneous variances (Levene’s test; Levene, 1960) and normality
(Shapiro–Wilks test; Shapiro and Wilk, 1965) were conducted for all continuous
data. The use of contrasts retained the within-group and between-group variances
of the 091 control and reference groups (45H72, 45H73, 46A65, and 44A89). With
the exception of motor activity and grip strength data, if neither preliminary test
was signiﬁcant, a one-way analysis of variance (ANOVA) was conducted using
p-adjusted linear contrasts (Snedecor and Cochran, 1967; Dempster et al., 1984).
If one or more of the preliminary tests was signiﬁcant, Dunn’s Type 1 p-adjusted lin-
ear contrasts were used (Dunn, 1964). For motor activity and grip strength data, if
neither preliminary test was signiﬁcant, a repeated measures analysis of variance
(RANOVA) followed by linear contrasts was conducted (Milliken and Johnson,
1984; Hocking, 1985). If one or more of the preliminary tests was signiﬁcant, a nor-
malizing, variance stabilizing transformation followed by RANOVA (Milliken and
Johnson, 1984) or a non-parametric test (Dunn, 1964) was conducted. Descriptive
FOB data were analyzed using Fisher’s Exact test (Fisher, 1985) with a Bonferron-
i-Holm correction (Holm, 1979).
Summary statistics (mean and standard deviation) were calculated for quanti-
tative response metrics from the reference diet groups (45H72, 45H73, 46A65,
and 44A89) to assess biological variability of the response variables evaluated in
the current study and served as a basis to interpret the biological signiﬁcance of
the comparative statistics. Where indicated, historical control ranges were obtained
from rodent subchronic studies conducted at DuPont Haskell within the 10 years
preceding this study using SD rats of similar age.3. Results
3.1. Characterization of processed canola fractions and experimental
diets
3.1.1. DH meal and RBD oil
In a dietary toxicity study where high inclusion of the test sub-
stance in the diet is desired for maximum exposure, canola seed
presents a problem in that antinutrients including ﬁber, lignin,tannins, and polyphenolic compounds are concentrated in the
seedcoat. These antinutrients reduce the feed value of canola meal
for rats and other non-ruminants by decreasing palatability and
digestibility and by interfering with protein utilization and nutri-
ent absorption (Bonnardeaux, 2007; OECD, 2011b; and Khajali
and Slominski, 2012). These factors restrict the use of canola meal
in diet rations for non-ruminants (Simbaya et al., 1992; Ikebudu
et al., 2000; Kracht et al., 2004; Bonnardeaux, 2007; Mohamadzadeh
et al., 2009). To overcome rodent diet formulation challenges with
canola, dehulled (DH) meal and reﬁned, bleached, deodorized
(RBD) oil processed from canola seed that had been partially de-
hulled (50%) was used in this study. This is not uncommon as edi-
ble oilseeds such as soybean, cottonseed, and sunﬂower are all
dehulled prior to processing into food and feed fractions.
Qualitative real-time PCR analysis conﬁrmed that molecular
event DP-Ø73496-4 was present only in DH meal from 73496
and 73496GLY canola and absent from all control and reference
(45H72, 45H73, 46A65, and 44A89) meals (data not shown). ELISA
analysis detected the GAT4621 protein in 73496 and 73496GLY
meals (0.71 and 0.65 ng/mg, respectively), was reduced by approx-
imately 90% compared with the concentrations measured in the
respective raw seed (data not shown); GAT4621 was not detected
in any other meal from the control or reference canola (assay lower
limit of quantitation (LLOQ) = 0.22 ng GAT4621/mg dry weight).
No nutrient deﬁciencies or above-threshold anti-nutrient or
contaminant concentrations that would have prevented any DH
meal or RBD oil source from being used in this study were observed
(data not shown). Compared with compositional standards of com-
mercially-produced defatted canola meal processed from intact
seeds (Canola Council of Canada, 2009; OECD, 2011a), the dehulled
meals used in this study contained different concentrations of cer-
tain analytes as expected due to partial removal of the seed coat.
The dehulling process reduced crude ﬁber content of the meals
relative to the high ﬁber content of non-dehulled meals prepared
from the same canola sources, thus enabling the high dietary inclu-
sions achieved in this study. Concentrations of crude protein, most
amino acids, and sinapine were higher, and concentrations of crude
ﬁber, ADF, NDF, and soluble and insoluble tannins were lower than
published ranges. Crude protein varied from 39.9% (reference
46A65) to 47.4% (73496GLY), approaching that of commercially-
processed dehulled soybean meal (47.5–49%; NOPA, 2012). Total
glucosinolate concentrations ranged from 9.83 lmol/g (reference
45A65) to 12.5 lmol/g (reference 45H72), within the range of total
glucosinolate content of canola meal processed at commercial
plants (Newkirk et al., 2003) and well below the 30 lmol/g allow-
able maximum (Canola Council of Canada, 2009). Vitamins and
minerals were of similar concentration relative to published indus-
try values with the following exceptions: iron and sodium concen-
tration were lower (except for reference 45H73 and 73496GLY)
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2011a,b); vitamin B6 concentration for reference 46A65 and vita-
min B5 concentration for 72496 and 73496GLY were lower than
the reported range (Canola Council of Canada, 2009). The fatty acid
proﬁles of the RBD oils were consistent with published standards
for canola oil (Codex, 1999); no erucic acid (C22:1) was detected.
During the routine pesticide residue screening of the canola
ingredients prior to diet formulation, the analytical lab (Columbia
Food Laboratories, Inc.) discovered a non-pesticide contaminant
in several of DH canola meal and RBD oil samples. A tentative iden-
tiﬁcationwasmade based on a GC–MS spectralmatchwith the trib-
utyl phosphate (TBP) entry in the National Institute of Standards
and Technology (NIST) database (http://www.nist.gov/srd/). A TBP
analytical standard was obtained, and a positive identiﬁcation
was conﬁrmed (data not shown). TBP is an industrial chemical used
as a hydraulic lubricant though the source in these samples was not
identiﬁed. The concentration of TBP in canola meals ranged from
0.20 ppm (reference 44A89) to 43.2 ppm (reference 45H72) and
in oil from 0.037 ppm (reference 46A65) to 1.32 ppm (reference
45H72). TBP was not detected in meal or oil from 73496 and
73496GLY or in oil from references 45H73 and 44A89.
No residues of pesticides (LODs = 0.02–0.08 ppm) or herbicides
(LODs ranging from 0.02 to 0.05 ppm) and no PCBs (LOD = 0.5 ppm)
were detected in any DH meal.
3.1.2. Experimental rodent diets
Experimental diets were produced by replacement of all com-
modity soybean fractions typically incorporated in Certiﬁed Ro-
dent LabDiet 5002 with DH canola meal and RBD canola oil. DH
canola meal fully replaced dehulled soybean meal on a protein
equivalency basis. Due to variation in the analyzed protein and
residual oil (crude fat) contents of the DH meals, dietary incorpo-
ration (weight percent of complete diet) ranged from 19.3%
(73496GLY meal) to 24.3% (reference 45H73 meal) and from
1.46% (control oil) to 2.06% (reference 45H72 oil) to produce the se-
ven isonitrogenous and isocaloric rodent diets fed in this study.
Diet composition is presented in Table 1.
Concentrations of proximate analytes, ﬁber, amino acids,
vitamins, and minerals were similar to those reported for PMI
Nutrition International, LLC Certiﬁed Rodent LabDiet 5002 (Purina
Mills Incorporated, 2009), although some analytes fell outside this
range. Such compositional differences were attributable to com-
plete substitution of soybean with canola. Crude protein, ﬁber
(crude, ADF, and NDF), fat, and somemineral (Cu, Na, and I) concen-
trations in one or more experimental diet exceeded LabDiet 5002
typical values, while concentrations of some essential amino acids
(Met, Arg, Phe, Ile, Thr, and Leu), vitamins (A, choline, B2, niacin,
and B6) and minerals (Fe and I) in one or more experimental diet
were below LabDiet 5002 typical values. Nevertheless, the concen-
trations of all analytes and/or their dietary equivalents satisﬁed the
NRC recommended minimum dietary intakes of these nutrients for
maintenance of the adult laboratory rat, and were well below die-
tary concentrations reported (if available) to cause adverse health
effects (NRC, 1995). Gross energy content ranged from 459 kcal/
100 g (control) to 468 kcal/100 g (reference 44A89), all well above
409 kcal/100 g typical of LabDiet 5002. Because rats compensate
for feed energy densitywith altered feed consumption tomeet calo-
ric needs (NRC, 1995), the high gross energies of these experimental
diets were considered to have no nutritional impact.
Low concentrations of the mycotoxins deoxynivalenol (vomi-
toxin) and ergot metabolites (ergosine, ergotamine, ergocornine,
ergocryptine, and ergocristine) were measured in all diets, and
moniliformin was quantiﬁed in all diets except the 091 control
and reference 45H73; all mycotoxin levels were below any concen-
tration reported to impact animal health (Arnold et al., 1986;
Morrissey et al., 1985; US FDA, 2010; Janssen et al., 2000; Abbaset al., 1990). Heavy metals (LOQ for arsenic = 0.50 ppm; LOQ for
lead = 1.00 ppm; LOQ for mercury = 0.100 ppm; LOQ for cad-
mium = 0.250 ppm) and pesticide or herbicide residues (LODs in
Section 3.1.1) were not detected in any diet (data not shown).
TBP was detected in the 091 control and reference 45H72,
45H73, and 46A65 diets; its presence and relative amount were
consistent with the concentrations of TBP in the respective canola
meals and oils. TBP dietary concentration ranged from 0.05 ppm (ref-
erence 45H73) to 6.3 ppm (reference 45H72), well below the rat sub-
chronic dietary NOAEL of 200 ppm (FMC Toxicology Laboratory,
1985).
Qualitative real-time PCR analysis conﬁrmed that molecular
event DP-Ø73496-4 was present only in diets formulated with
DH meal and RBD oil from 73496 and 73496GLY canola and absent
from all control and reference (45H72, 45H73, 46A65, and 44A89)
diets (data not shown). ELISA analysis detected low but quantiﬁ-
able amounts of the GAT4621 protein in the 73496 and
73496GLY diets (0.24 and 0.19 ng/mg, respectively). GAT4621
was not detected in any other diet (diet LLOQ = 0.11 ng/mg dry
weight). Analysis of 73496 and 73496GLY diets sampled at the
time of manufacture conﬁrmed the homogeneous distribution of
the GAT4621 protein (data not shown). Analysis of the 73496
and 73496GLY diets over the course of the study demonstrated
that GAT4621 was presumably stable under ambient conditions
of use (data not shown). However, under long-term refrigerated
storage, detectable GAT4621 protein in the 73496 and 73496GLY
diets fell to 0.14 ng/mg and below the LLOQ, respectively.
3.2. Clinical observations, clinical pathology and anatomic pathology
3.2.1. Mortality, body weights, food consumption and neurobehavioral
assessment
In this study, 3 of the 168 rats died before scheduled sacriﬁce.
One 091 control group male was found dead on day 54; one refer-
ence 44A89 male was sacriﬁced in extremis on day 50. The cause of
death for both rats was urinary bladder calculi. Urinary tract calcu-
li, and associated inﬂammation and mucosal hyperplasia, are com-
mon background lesions in control rats of this age and strain
(Paterson, 1979). One 73496 male was sacriﬁced for humane rea-
sons on Day 79 due to bilaterally enlarged forelimb carpi (wrists).
Osteoarthritis was observed microscopically. Although the cause of
the osteoarthritis was not determined, it was considered incidental
and not related to consumption of diets containing DH meal and
RBD oil from 73496 canola.
While mean female body weights and body weight gains were
similar to the 091 control group mean, overall mean male body
weights were greater in the 73496 and 73496GLY groups com-
pared with those in the 091 control group (Fig. 1). Final mean body
weights (Day 91) for 73496 and 73496GLY males were 109.9%
(p < 0.05) and 107.8% (p > 0.05) of the 091 control mean, respec-
tively. These body weights were within the range of historical
control data collected at the test facility, whereas the 091 control
means were atypically low and fell outside the range of historical
control means and below the means all reference groups (45H72,
45H73, 46A65, 44A89). The statistical difference in terminal body
weights between male rats in the 091 control group and both the
73496 and 73496GLY groups was attributable the lower than
average body weights of males in the 091 control group. Therefore,
the differences in mean male body weight were considered
non-adverse.
In one feeding interval (Day 84–91), there were was a difference
(p < 0.05) in food consumption in males between the 73496 and
091 control group but otherwise food consumption was similar
regardless of treatment group (Fig. 2).
There were no toxicologically signiﬁcant differences for fore-
limb or hindlimb grip strength in males or females when data from
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the control diet group (data not shown). Male forelimb and hind-
limb grip strength were slightly higher in the 73496 and
73496GLY groups compared with controls, with statistical signiﬁ-
cance in the 73496 and 73496GLY groups for forelimb only (data
not shown). The higher mean values correlated with the statisti-
cally higher mean body weights observed in the same groups, were
speciﬁc to males, were within the range of historical control values,
and were not associated with any relevant differences in clinical
observations, clinical pathology variables, or gross or microscopic
pathology variables. Therefore, the differences in male forelimb
and hindlimb grip strength were considered secondary to differ-
ences in body weight and non-adverse. Further, no biologically sig-
niﬁcant or statistically signiﬁcant differences for behavioral
parameters or motor activity were observed in 73496 and
73496GLY groups compared with data from the 091 control diet
group (data not shown).
3.2.2. Hematology, coagulation, clinical chemistry, and urinalysis
There were no statistically signiﬁcant or treatment-related dif-
ferences in the mean values of any measured hematology and
coagulation variable between either the 73496 or 73496GLY0
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There were no treatment-related adverse effects in the mean
values of clinical chemistry variables (Tables 4 and 5); however,
two statistical differences were observed. The mean serum calcium
concentration (CALC) was higher (p < 0.05) in male rats consuming
the 73496 diet (3% above the 091 control mean). The higher cal-
cium concentration was not considered to be adverse and was
unrelated to diet for several reasons. The range of individual cal-
cium values for male rats fed the 73496 diet (9.7–11.1 mg/dL)
was similar to the range of individual values for the concurrent
control group (9.5–10.9 mg/dL) except for two animals which
had minimally higher calcium values. Additionally, the individual
calcium values for male rats fed 73496 were within the study ref-
erence groups’ range of individual values of 9.4–11.9 mg/dL. There
were no correlative differences observed in inorganic phosphorus
and the direction of the difference in calcium is not biologically rel-
evant. There were no differences in albumin in male rats fed the
73496 diet, as increases in albumin are necessarily associated with
physiologically appropriate increases in calcium (Latimer, 2011).
Therefore, the observed higher mean calcium concentration was
considered to be unrelated to diet.49 56 63 70 77 84 91
on Test
45H72 45H73 46A65 44A89
Males
Females
od consumption.
Table 2
Hematology and coagulation values for male rats (mean ± SD).
091 73496 73496GLY 45H72 45H73 46A65 44A89
n = 11 n = 11 n = 12 n = 12 n = 12 n = 12 n = 11
RBC (106/lL) 8.69 ± 0.27 8.97 ± 0.33 8.72 ± 0.38 8.76 ± 0.41 8.56 ± 0.41 a 8.74 ± 0.41 a 8.92 ± 0.48
HGB (g/dL) 14.9 ± 0.3 15.4 ± 0.7 15.3 ± 0.4 15.1 ± 0.7 14.8 ± 1.0 a 14.8 ± 0.7 a 15.2 ± 0.4
HCT (%) 45.5 ± 1.2 47.3 ± 2.2 46.7 ± 1.4 46.4 ± 2.4 45.8 ± 2.4 a 45.8 ± 2.3 a 46.4 ± 1.6
MCV (fL) 52.4 ± 1.1 52.7 ± 1.3 53.6 ± 1.6 53.0 ± 1.6 53.5 ± 1.6 a 52.5 ± 1.8 a 52.1 ± 1.4
MCH (pg) 17.2 ± 0.4 17.1 ± 0.4 17.6 ± 0.6 17.2 ± 0.6 17.2 ± 0.8 a 16.9 ± 0.6 a 17.0 ± 0.6
MCHC (g/dL) 32.7 ± 0.3 32.5 ± 0.3 32.7 ± 0.4 32.5 ± 0.5 32.2 ± 0.8 a 32.3 ± 0.4 a 32.7 ± 0.4
RDW (%) 12.7 ± 0.4 12.4 ± 0.5 12.4 ± 0.4 12.8 ± 0.5 12.9 ± 0.6 a 13.1 ± 0.4 a 12.7 ± 0.4
ARET (103/lL) 139.01 ± 27.47 148.93 ± 18.94 145.53 ± 16.60 149.81 ± 29.75 153.92 ± 28.05 a 160.73 ± 25.85 a 152.75 ± 19.16
PLT (103/lL) 1000 ± 77 969 ± 112 926 ± 110 977 ± 128 1030 ± 175 a 940 ± 123 a 1008 ± 144
WBC (103/lL) 11.29 ± 2.45 10.61 ± 1.60 11.30 ± 2.40 10.79 ± 1.45 9.82 ± 1.89 a 11.47 ± 2.48 a 11.59 ± 2.56
ANEU (103/lL) 1.09 ± 0.16 1.24 ± 0.22 1.43 ± 0.69 1.06 ± 0.20 1.14 ± 0.26 a 1.39 ± 0.46 a 1.13 ± 0.25
ALYM (103/lL) 9.72 ± 2.23 8.86 ± 1.52 9.36 ± 1.85 9.27 ± 1.38 8.22 ± 1.72 a 9.60 ± 2.47 a 9.94 ± 2.27
AMON (103/lL) 0.24 ± 0.12 0.28 ± 0.07 0.28 ± 0.12 0.27 ± 0.06 0.27 ± 0.09 a 0.25 ± 0.06 a 0.27 ± 0.09
AEOS (103/lL) 0.12 ± 0.06 0.13 ± 0.05 0.13 ± 0.04 0.11 ± 0.03 0.11 ± 0.06 a 0.11 ± 0.05 a 0.12 ± 0.05
ABAS (103/lL) 0.03 ± 0.02 0.04 ± 0.01 0.03 ± 0.02 0.03 ± 0.01 0.03 ± 0.01 a 0.04 ± 0.02 a 0.04 ± 0.05
ALUC (103/lL) 0.09 ± 0.05 0.06 ± 0.02 0.06 ± 0.03 0.07 ± 0.02 0.05 ± 0.03 a 0.07 ± 0.04 a 0.08 ± 0.05
PT (sec) 11.8 ± 0.8 11.7 ± 1.1 11.8 ± 1.0 11.6 ± 0.7 11.6 ± 0.7 11.9 ± 1.4 12.0 ± 0.8
APTT (sec) 16.7 ± 1.6 b 16.3 ± 1.5 16.6 ± 1.4 16.3 ± 1.3 a 15.8 ± 1.3 16.9 ± 1.8 17.3 ± 2.1
There were no statistically signiﬁcant differences from 091 control group at p < 0.05.
a n = 11.
b n = 10.
Table 3
Hematology and coagulation values for female rats (mean ± SD).
091 73496 73496GLY 45H72 45H73 46A65 44A89
n = 12 n = 12 n = 12 n = 12 n = 12 n = 12 n = 12
RBC (106/lL) 7.93 ± 0.26 8.12 ± 0.30 8.23 ± 0.34 7.88 ± 0.35 8.15 ± 0.41b 7.73 ± 0.33 8.13 ± 0.25
HGB (g/dL) 14.5 ± 0.6 14.9 ± 0.5 14.9 ± 0.4 14.2 ± 0.6 14.7 ± 0.6b 14.2 ± 0.5 14.6 ± 0.4
HCT (%) 43.8 ± 1.9 45.0 ± 1.4 44.7 ± 1.2 43.1 ± 1.9 44.1 ± 1.9b 42.7 ± 1.4 44.0 ± 0.9
MCV (fL) 55.2 ± 1.1 55.4 ± 2.1 54.4 ± 1.4 54.7 ± 1.8 54.2 ± 1.6b 55.2 ± 1.8 54.1 ± 1.2
MCH (pg) 18.3 ± 0.4 18.4 ± 0.7 18.1 ± 0.5 18.1 ± 0.6 18.0 ± 0.4b 18.4 ± 0.7 18.0 ± 0.6
MCHC (g/dL) 33.1 ± 0.4 33.1 ± 0.4 33.3 ± 0.4 33.1 ± 0.3 33.2 ± 0.7 b 33.4 ± 0.4 33.3 ± 0.5
RDW (%) 11.4 ± 0.5 11.3 ± 0.4 11.3 ± 0.4 11.6 ± 0.5 11.5 ± 0.5b 11.9 ± 0.5 11.4 ± 0.5
ARET (x103/lL) 125.24 ± 32.14 129.72 ± 27.24 114.14 ± 24.28 133.35 ± 24.81 121.79 ± 25.25b 138.55 ± 29.05 113.77 ± 29.10
PLT (x103/lL) 904 ± 97 953 ± 160 940 ± 134 946 ± 88 919 ± 70b 874 ± 315 895 ± 120
WBC (103/lL) 6.89 ± 1.39 7.87 ± 2.40 6.88 ± 2.23 6.89 ± 2.49 7.67 ± 2.08b 7.21 ± 2.17 7.09 ± 1.57
ANEU (103/lL) 0.95 ± 0.46 0.95 ± 0.40 0.98 ± 0.42 0.91 ± 0.25 0.82 ± 0.28b 1.00 ± 0.42 0.73 ± 0.23
ALYM (103/lL) 5.63 ± 1.11 6.53 ± 2.12 5.56 ± 1.86 5.68 ± 2.19 6.51 ± 1.75b 5.88 ± 1.99 6.06 ± 1.56
AMON (103/lL) 0.18 ± 0.07 0.21 ± 0.09 0.18 ± 0.09 0.17 ± 0.09 0.20 ± 0.10b 0.17 ± 0.07 0.15 ± 0.08
AEOS (103/lL) 0.07 ± 0.02 0.11 ± 0.05 0.10 ± 0.06 0.08 ± 0.03 0.08 ± 0.03b 0.09 ± 0.04 0.09 ± 0.04
ABAS (103/lL) 0.01 ± 0.01 0.02 ± 0.01 0.02 ± 0.01 0.02 ± 0.01 0.02 ± 0.01b 0.01 ± 0.01 0.01 ± 0.01
ALUC (103/lL) 0.04 ± 0.02 0.05 ± 0.03 0.04 ± 0.03 0.04 ± 0.03 0.05 ± 0.02b 0.04 ± 0.02 0.05 ± 0.03
PT (sec) 10.2 ± 0.2 10.2 ± 0.2 10.2 ± 0.2 10.2 ± 0.3 10.2 ± 0.2 10.2 ± 0.3 10.4 ± 0.5
APTT (sec) 15.6 ± 1.3a 15.4 ± 1.1c 14.9 ± 0.8b 14.9 ± 0.9 15.1 ± 0.9 15.2 ± 0.9b 15.7 ± 1.3c
There were no statistically signiﬁcant differences from 091 control group at p < 0.05.
a n = 8.
b n = 11.
c n = 10.
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fed the 73496GLY diet (5% below the control). The lower mean
potassium concentration was considered to be unrelated to diet
for several reasons. Individual potassium values for male rats fed
73496GLY ranged from 4.22 to 4.91 mmol/L, slightly lower than
the range of individual values for the concurrent control group
(4.35–5.05 mmol/L). However, the individual potassium values
for male rats fed the 73496GLY diet were within the study refer-
ence groups’ range of individual values of 4.02–6.17 mmol/L.
Importantly, there were no differences in sodium or chloride con-
centrations in male rats fed the 73496GLY diet, which would be ex-
pected with a physiologically signiﬁcant alteration in serum
potassium concentration (Latimer, 2011). Therefore, the observed
lower mean potassium concentration was considered to be unre-
lated to diet.
There were no statistically signiﬁcant or treatment-related dif-
ferences in urinalysis parameters in male or female rats fed dietscontaining 73496 or 73496GLY canola fractions, compared with
data from the control diet group (Table 6).
3.2.3. Organ weights
There were no diet-related organ weight differences in the
73496 or 73496GLY groups when compared with the respective
male and female control groups (Table 7). The only statistical
(p < 0.05) organ weight difference was an 8% lower mean relative
heart weight of the 73496GLY group females compared with the
091 control group mean. This observation was considered spurious
for several reasons. The mean absolute heart weight (0.983 g) was
only 5% less than the control mean (1.032 g) and was within the
range of the means of the 4 reference groups and the controls
(0.974–1.032 g). The lower mean relative heart weight was primar-
ily the result of the 73496GLYmean terminal body weight being 4%
greater than the 091 control mean. Importantly, there were no
gross or microscopic pathology correlates. Additionally, there was
Table 4
Serum chemistry values for male rats (mean ± SD).
091 73496 73496GLY 45H72 45H73 46A65 44A89
n = 11 n = 11 n = 12 n = 12 n = 12 n = 12 n = 11
AST (U/L) 90 ± 24 82 ± 10 89 ± 20 81 ± 20 96 ± 39 78 ± 13 82 ± 23
ALT (U/L) 33 ± 15 29 ± 5 30 ± 5 27 ± 4 30 ± 13 27 ± 2 29 ± 3
SDH (U/L) 8.6 ± 3.9 10.7 ± 2.6 10.2 ± 3.5 9.6 ± 3.0 9.5 ± 4.7 8.3 ± 1.6 7.8 ± 2.3
ALKP (U/L) 87 ± 23 102 ± 34 93 ± 16 105 ± 24 91 ± 22 94 ± 22 97 ± 17
BILI (mg/dL) 0.14 ± 0.02 0.13 ± 0.02 0.15 ± 0.02 0.13 ± 0.02 0.14 ± 0.02 0.14 ± 0.01 0.14 ± 0.03
BUN (mg/dL) 12 ± 1 12 ± 1 11 ± 1 12 ± 2 12 ± 2 11 ± 1 12 ± 1
CREA (mg/dL) 0.30 ± 0.02 0.31 ± 0.03 0.31 ± 0.02 0.29 ± 0.02 0.30 ± 0.04 0.29 ± 0.03 0.29 ± 0.02
CHOL (mg/dL) 73 ± 10 77 ± 19 80 ± 18 73 ± 17 65 ± 11 69 ± 15 77 ± 14
TRIG (mg/dL) 55 ± 16 83 ± 38 81 ± 29 68 ± 34 52 ± 19 70 ± 54 73 ± 30
GLUC (mg/dL) 124 ± 10 126 ± 17 120 ± 13 119 ± 16 128 ± 35 117 ± 15 129 ± 17
TP (g/dL) 6.6 ± 0.2 6.7 ± 0.3 6.8 ± 0.3 6.6 ± 0.3 6.5 ± 0.5 6.7 ± 0.3 6.8 ± 0.2
ALB (g/dL) 3.5 ± 0.1 3.6 ± 0.2 3.5 ± 0.1 3.5 ± 0.2 3.5 ± 0.3 3.5 ± 0.2 3.6 ± 0.1
GLOB (g/dL) 3.1 ± 0.2 3.1 ± 0.2 3.3 ± 0.2 3.1 ± 0.2 3.0 ± 0.2 3.2 ± 0.2 3.2 ± 0.2
CALC (mg/dL) 9.9 ± 0.4 10.2 ± 0.5* 10.2 ± 0.7 10.0 ± 0.4 10.0 ± 0.3 10.1 ± 0.7 10.0 ± 0.3
IPHS (mg/dL) 5.9 ± 0.3 6.3 ± 0.6 6.0 ± 0.7 6.1 ± 0.4 6.5 ± 0.7 6.1 ± 0.4 6.0 ± 0.5
NA (mmol/L) 145.1 ± 4.5 146.0 ± 5.1 143.1 ± 6.3 144.5 ± 4.4a 144.3 ± 4.8 143.0 ± 4.8 143.2 ± 4.1
K (mmol/L) 4.76 ± 0.21 4.82 ± 0.30 4.50 ± 0.19* 4.65 ± 0.20a 4.82 ± 0.49 4.58 ± 0.27 4.62 ± 0.26
CL (mmol/L) 106.5 ± 2.8 106.5 ± 3.9 104.1 ± 4.6 105.6 ± 2.8a 105.9 ± 3.2 104.5 ± 3.9 104.4 ± 2.9
TBA (lmol/L) 18.3 ± 15.3 18.8 ± 10.3 31.8 ± 26.6 25.8 ± 21.4 19.8 ± 16.5 19.5 ± 15.7 24.1 ± 22.8
* Statistically signiﬁcant differences from 091 Control group at p < 0.05 by Dunn’s Type I test for linear contrasts.
a n = 11.
Table 5
Serum chemistry values for female rats (mean ± SD).
091 734/96 73496GLY 45H72 45H73 46A65 44A89
n = 12 n = 12 n = 12 n = 12 n = 12 n = 12 n = 12
AST (U/L) 97 ± 36 80 ± 13 85 ± 20 77 ± 12 77 ± 10 86 ± 20 88 ± 20
ALT (U/L) 37 ± 48 23 ± 3 25 ± 3 21 ± 3 25 ± 7 26 ± 14 28 ± 13
SDH (U/L) 9.1 ± 7.2 8.5 ± 4.5 8.4 ± 6.6 8.0 ± 1.4 12.4 ± 8.2 8.3 ± 4.2 9.3 ± 2.4
ALKP (U/L) 50 ± 22 54 ± 20 45 ± 7 59 ± 23 62 ± 25 50 ± 11 51 ± 13
BILI (mg/dL) 0.20 ± 0.03 0.21 ± 0.03 0.20 ± 0.04 0.19 ± 0.03 0.22 ± 0.05 0.23 ± 0.02 0.19 ± 0.03
BUN (mg/dL) 13 ± 2 13 ± 2 13 ± 1 14 ± 3 14 ± 2 14 ± 1 13 ± 2
CREA (mg/dL) 0.36 ± 0.03 0.37 ± 0.05 0.38 ± 0.05 0.38 ± 0.06 0.38 ± 0.08 0.37 ± 0.04 0.36 ± 0.03
CHOL (mg/dL) 67 ± 9 75 ± 14 71 ± 16 67 ± 13 67 ± 12 70 ± 13 68 ± 15
TRIG (mg/dL) 30 ± 6 36 ± 9 37 ± 14 32 ± 6 30 ± 7 29 ± 8 35 ± 9
GLUC (mg/dL) 110 ± 9 113 ± 16 116 ± 14 108 ± 8 112 ± 10 115 ± 9 110 ± 9
TP (g/dL) 7.0 ± 0.3 6.9 ± 0.3 7.0 ± 0.4 6.9 ± 0.3 6.9 ± 0.4 7.1 ± 0.5 6.8 ± 0.3
ALB (g/dL) 4.0 ± 0.2 3.9 ± 0.2 3.9 ± 0.2 3.9 ± 0.2 4.0 ± 0.3 4.0 ± 0.3 3.8 ± 0.2
GLOB (g/dL) 3.0 ± 0.2 3.0 ± 0.2 3.1 ± 0.2 2.9 ± 0.1 3.0 ± 0.2 3.1 ± 0.2 3.0 ± 0.2
CALC (mg/dL) 10.2 ± 0.5 10.0 ± 0.3 9.9 ± 0.4 10.0 ± 0.3 10.0 ± 0.4 10.1 ± 0.4 9.7 ± 0.4
IPHS (mg/dL) 4.5 ± 0.4 4.7 ± 0.9 4.7 ± 0.8 5.0 ± 0.6 4.9 ± 0.8 4.5 ± 0.6 4.7 ± 0.6
NA (mmol/L) 141.2 ± 3.8 139.6 ± 4.4 140.8 ± 2.9 138.9 ± 2.0 141.3 ± 1.8 136.9 ± 9.1 144.0 ± 7.0
K (mmol/L) 4.31 ± 0.23 4.26 ± 0.36 4.36 ± 0.26 4.21 ± 0.22 4.23 ± 0.20 4.07 ± 0.42 4.41 ± 0.28
CL (mmol/L) 106.2 ± 3.0 105.3 ± 2.7 105.4 ± 2.5 104.9 ± 2.0 105.6 ± 2.4 102.5 ± 6.4 108.5 ± 5.5
TBA (lmol/L) 26.9 ± 32.0 36.0 ± 26.8 32.1 ± 25.8 40.3 ± 35.1 33.0 ± 16.8 28.9 ± 24.9 29.5 ± 26.9
There were no statistically signiﬁcant differences from 091 control group at p < 0.05.
Table 6
Urinalysis values for male and female rats (mean ± SD).
091 73496 73496GLY 45H72 45H73 46A65 44A89
n = 11 n = 11 n = 12 n = 12 n = 12 n = 12 n = 11
Males
UVOL (mL) 8.3 ± 4.3 10.1 ± 5.3 10.2 ± 10.0 10.3 ± 8.0 8.3 ± 5.0 16.3 ± 17.7 13.4 ± 11.4
SG 1.035 ± 0.013 1.036 ± 0.021 1.037 ± 0.015 1.036 ± 0.018 1.036 ± 0.013 1.029 ± 0.015 1.036 ± 0.025
pH 6.5 ± 0.4 6.5 ± 0.4 6.7 ± 0.4 6.6 ± 0.2 6.5 ± 0.4 6.5 ± 0.2 6.5 ± 0.4
URO (EU/dL) 0.2 ± 0.0 0.2 ± 0.0 0.3 ± 0.2 0.2 ± 0.0 0.2 ± 0.0 0.2 ± 0.0 0.2 ± 0.0
UMTP (mg/dL) 161 ± 74 178 ± 131 173 ± 86 166 ± 95 179 ± 78 141 ± 80 155 ± 97
Females
n = 12 n = 12 n = 12 n = 12 n = 12 n = 12 n = 12
UVOL (mL) 14.6 ± 10.8a 8.2 ± 7.4 14.9 ± 8.1 11.5 ± 14.8 6.6 ± 4.6 9.9 ± 8.1a 7.4 ± 4.5a
SG 1.018 ± 0.009a 1.026 ± 0.019a 1.015 ± 0.005 1.027 ± 0.022 1.027 ± 0.012 1.022 ± 0.008a 1.030 ± 0.016a
pH 6.6 ± 0.3a 6.5 ± 0.3a 6.5 ± 0.3 6.5 ± 0.3 6.3 ± 0.3 6.3 ± 0.3a 6.5 ± 0.5a
URO (EU/dL) 0.2 ± 0.0a,b 0.2 ± 0.0a,b 0.2 ± 0.0b 0.2 ± 0.0b 0.2 ± 0.0b 0.2 ± 0.0a,b 0.2 ± 0.0a,b
UMTP (mg/dL) 20 ± 12a 35 ± 39 16 ± 7 36 ± 41 27 ± 11 24 ± 10a 32 ± 18a
There were no statistically signiﬁcant differences from 091 control group at p < 0.05.
a n = 11.
b Due to lack of variability among group means, statistical analyses were not conducted.
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Table 7
Organ/body weight ratios for male and female rats (mean* 100 ± SD).
091 73496 73496GLY 45H72 45H73 46A65 44A89
n = 11 n = 11 n = 12 n = 12 n = 12 n = 12 n = 11
Males
Body weight (ﬁnal, g) 496.3 ± 37.6 530.0 ± 74.3 531.6 ± 34.7 502.9 ± 50.8 510.8 ± 36.5 513.7 ± 45.0 498.8 ± 32.6
Adrenals 0.011 ± 0.002 0.011 ± 0.002 0.010 ± 0.001 0.010 ± 0.001a 0.010 ± 0.001 0.011 ± 0.001 0.010 ± 0.001
Brain 0.440 ± 0.029 0.415 ± 0.048 0.416 ± 0.021 0.438 ± 0.036 0.423 ± 0.035 0.427 ± 0.023 0.426 ± 0.032
Epididymides 0.295 ± 0.034 0.284 ± 0.041 0.271 ± 0.030 0.284 ± 0.056 0.283 ± 0.028 0.285 ± 0.018 0.287 ± 0.028
Heart 0.306 ± 0.024 0.306 ± 0.034 0.289 ± 0.017 0.300 ± 0.030 0.307 ± 0.020 0.309 ± 0.024 0.304 ± 0.021
Kidneys 0.674 ± 0.055 0.677 ± 0.069 0.656 ± 0.053 0.695 ± 0.056 0.697 ± 0.059 0.705 ± 0.047 0.654 ± 0.042
Liver 2.805 ± 0.180 2.837 ± 0.366 2.761 ± 0.178 2.808 ± 0.193 2.763 ± 0.156 2.900 ± 0.238 2.828 ± 0.266
Spleen 0.153 ± 0.024 0.146 ± 0.018 0.139 ± 0.018 0.142 ± 0.016a 0.134 ± 0.010 0.159 ± 0.022 0.145 ± 0.017
Testes 0.695 ± 0.059 0.674 ± 0.083 0.641 ± 0.071 0.693 ± 0.181 0.709 ± 0.074 0.701 ± 0.051 0.699 ± 0.077
Thymus 0.055 ± 0.013 0.060 ± 0.012 0.060 ± 0.013 0.053 ± 0.014 0.048 ± 0.014 0.064 ± 0.011 0.057 ± 0.013
Females
n = 12 n = 12 n = 12 n = 12 n = 12 n = 12 n = 12
Body weight (ﬁnal, g) 264.2 ± 14.9 268.9 ± 30.8 275.2 ± 26.0 264.4 ± 23.5 260.7 ± 21.9 260.1 ± 19.3 260.5 ± 23.3
Adrenals 0.024 ± 0.004 0.022 ± 0.003 0.021 ± 0.004 0.023 ± 0.002 0.022 ± 0.004 0.024 ± 0.007 0.023 ± 0.005
Brain 0.731 ± 0.033 0.739 ± 0.084 0.714 ± 0.066 0.741 ± 0.061 0.745 ± 0.041 0.758 ± 0.056 0.759 ± 0.064
Heart 0.391 ± 0.030 0.376 ± 0.032 0.358 ± 0.019* 0.378 ± 0.029 0.372 ± 0.024 0.375 ± 0.027 0.373 ± 0.024
Kidneys 0.751 ± 0.096 0.723 ± 0.079 0.699 ± 0.042 0.730 ± 0.049 0.750 ± 0.052 0.722 ± 0.042 0.745 ± 0.055
Liver 2.826 ± 0.177 2.714 ± 0.140 2.667 ± 0.209 2.805 ± 0.121 2.814 ± 0.190 2.821 ± 0.192 2.733 ± 0.160
Ovaries 0.049 ± 0.008 0.046 ± 0.006 0.043 ± 0.008 0.052 ± 0.007 0.047 ± 0.008 0.050 ± 0.007 0.052 ± 0.009
Spleen 0.181 ± 0.023 0.174 ± 0.019 0.189 ± 0.036 0.185 ± 0.015 0.173 ± 0.018 0.191 ± 0.029 0.181 ± 0.012
Thymus 0.078 ± 0.022 0.088 ± 0.019 0.082 ± 0.019 0.077 ± 0.023 0.070 ± 0.021 0.066 ± 0.024 0.072 ± 0.018
Uterus 0.310 ± 0.167 0.244 ± 0.068 0.273 ± 0.103 0.255 ± 0.073 0.254 ± 0.087 0.285 ± 0.080 0.253 ± 0.041
* Statistically signiﬁcant difference from 091 control group at p < 0.05 by Dunn’s Type I test for linear contrasts.
a n = 11.
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females in the 73496 group nor between male heart weight param-
eters in either treatment group and the 091 control group.
3.2.4. Gross pathology and histopathology
No diet-related gross observations were noted following sacri-
ﬁce (data not shown). All microscopic ﬁndings in this study were
consistent with normal background lesions in rats of this age and
strain (Table 8). Minimal cardiomyopathy was observed in 4 of
the 12 males from the 73496GLY group. This is commonly ob-
served as a background lesion in animals of this strain and age
and was not treatment related (Keenan et al., 2010 and Chanut
et al., 2013). In this study the incidence was higher than that ob-
served in the 091 control group however this difference is actually
attributable to the lower incidence observed in the 091 control
group (1/11) compared with control groups from previous studies
of similar design in which the test substance was soybeans or
maize grain where it has been observed in as high as 7/12 male
control animals (Hammond et al., 2004, 2006a, 2006b; Appenzeller
et al., 2008, 2009; Delaney et al., 2008c, 2013; Healy et al., 2008).
Tissues from rats fed the four reference diets (45H72, 45H73,
46A65, and 44A89) were not examined microscopically, except
for the reference 44A89 male that was euthanized on day 50 and
the thymus glands from females in all four reference groups (data
not shown). Thymus glands from reference group females were
examined to clarify the background incidence of epithelial hyper-
plasia in this study. The incidence of this latter ﬁnding, graded as
‘‘minimal,’’ ranged from 0/12 in the 091 control, 73496GLY, and
45H72 diet groups to 3/12 in the 73496 and 45H73 diet groups,
was determined not to be test diet-related. Therefore it was con-
cluded that consumption of diets containing DH meal and RBD
oil from 73496 or 73496GLY canola did not result in any diet-re-
lated effects on gross or microscopic pathology.
4. Discussion
Event DP-Ø73496-4 (73496 canola) is a genetically modiﬁed
canola that expresses the GAT4621 protein for tolerance to thenon-selective herbicide glyphosate. This protein was originally
identiﬁed in a strain of Bacillus licheniformis and modiﬁed through
multiple rounds of gene shufﬂing to improve the activity toward
acetylating and thereby detoxifying glyphosate (Castle et al.,
2004; Siehl et al., 2005). It is similar in sequence to the GAT4601
protein that has been utilized in other GM crops (i.e., DP
356Ø43-5 soybeans; Appenzeller et al., 2008). As with other pro-
teins used in agricultural biotechnology, the GAT4621 protein
was subjected to extensive testing to determine whether the pro-
tein had potential to act as an allergen or toxin (Codex 2003;
Delaney et al., 2008a). Similar to the GAT4601 protein, the
GAT4621 protein does not have potential to act as either an aller-
gen or a toxin based on established testing guidelines (Delaney
et al., 2008b).
In the current study, seed from 73496 canola that was either un-
treated (73496) or sprayed in ﬁeldwith glyphosate (73496GLY), the
non-transformed near isogenic non-GM control canola (091), or one
of 4 different commercially available non-GM canola varieties (Pio-
neer brand products 45H72, 45H73, 46A65, and 44A89) was pro-
cessed into dehulled/defatted toasted meal and reﬁned, bleached,
deodorized oil. Compositional data from the respective sources
was then used to formulate and produce diets nutritionally consis-
tent with PMI Nutrition International, LLC Certiﬁed Rodent LabDi-
et 5002 using the canola fractions to replace all soybean fractions
typically used in the formulation of these diets.
Rodent diets formulated for this study contained approximately
19–24% DH canola meal and 1.5–2% RBD canola oil by weight. The
amount of DH canola meal incorporated into the experimental
diets was similar to the highest incorporation of test substance
(20% by weight; cruciferin-rich and napin-rich canola protein iso-
lates) added to a synthetic protein-free rodent diet and fed subch-
ronically to rats with no evidence of adverse effects (Mejia et al.,
2009a, 2009b). Although some studies have reported adverse ef-
fects in Kyoto Wistar and spontaneously hypertensive rats con-
suming canola oil as the only dietary source of fats for extended
periods of time, these effects do not appear to occur in other rat
strains (Naito et al., 2000a, 2000b; Ohara et al., 2008a, 2008b,
2009).
Table 8
Summary of microscopic pathology observations.
Tissue Finding Males Females
091 73496 73496GLY 091 73496 73496GLY
n = 11 n = 11 n = 12 n = 12 n = 12 n = 12
Cecum Mucosal inﬂammation 1 0 3 0 0 1
Minimal [1] [0] [2] [0] [0] [0]
Mild [0] [0] [1] [0] [0] [1]
Epididymides Oligospermia/germ cell debris, unilateral, moderate* 0 0 1 – – –
Sperm granuloma, mild 0 0 1 – – –
Eyes Fold /rosette, retinal 0 0 0 1 1 1
Minimal [0] [0] [0] [0] [1] [1]
Mild [0] [0] [0] [1] [0] [0]
Heart Cardiomyopathy, minimal 1 0 4 0 0 0
Kidneys Lymphoid aggregates, minimal* 0 1 0 0 0 1
Chronic progressive nephropathy, minimal 4 2 2 0 0 0
Hyaline droplets, minimal 1 0 2 0 0 0
Hydronephrosis, unilateral, minimal* 1 0 1 1 0 0
Liver Fatty change, median cleft 1 2 1 1 1 2
Minimal [1] [2] [1] [1] [1] [1]
Mild [0] [0] [0] [0] [0] [1]
Mononuclear cell inﬁltrate 6 6 7 8 5 7
Minimal [6] [6] [7] [7] [5] [7]
Mild [0] [0] [0] [1] [0] [0]
Lungs Histiocytosis, alveolar, minimal 2 0 1 1 0 3
Mandibular lymph node Erythrocytosis/hemosiderosis, sinus, minimal 0 1 0 2 2 3
Hyperplasia, plasma cell, mild 0 0 1 0 0 1
Nose Degeneration/regeneration, oldfactory epithelium, minimal 0 0 0 2 5 2
Inﬂammation, turbinates, minimal 1 1 0 0 0 1
Pancreas Aggregates, lymphoid, minimal 0 0 0 0 1 1
Peyer’s patch Mineralization, focal/multifocal 0 1 0 0 0 a 1
Minimal [0] [1] [0] [0] [0] [0]
Mild [0] [0] [0] [0] [0] [1]
Prostate Aggregates, lymphoid 6 6 8 – – –
Minimal [3] [6] [6] – – –
Mild [2] [0] [2] – – –
Moderate [1] [0] [0] – – –
Salivary gland Aggregates, lymphoid, minimal 0 1 2 0 0 0
Teeth Inﬂammation, periodontal 2 1 4 1 4 1
Minimal [1] [1] [3] [1] [4] [1]
Mild [1] [0] [1] [0] [0] [0]
Thymus Cysts, minimal 0 0 0 0 1 1
Hyperplasia, epithelial, minimal 0 0 0 0 3 0
Thyroid gland Aggregates, lymphoid, minimal 0 0 1 0 0 1
Cyst, ultimobranchial, 1 2 0 1 1 0
Hypertrophy, follicular cell 5 3 5 0 0 0
Minimal [4] [3] [5] [0] [0] [0]
Mild [1] [0] [0] [0] [0] [0]
Urinary bladder Aggregates, lymphoid, minimal 0 1 1 1 0 0
Uterus Dilatation – – – 5 6 4
Mild – – – [2] [1] [0]
Minimal – – – [1] [5] [4]
Moderate - – – [2] [0] [0]
Table reports observations where the combined incidence across treatment groups was greater than 1. A total of 40 tissues were examined from each treatment group (n = 12/
sex/group except where indicated).
a n = 11.
* Also observed in one animal from the 45H72 reference group that died earlier in the study.
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rats consuming the 73496 or 73496GLY and the control diets, they
were demonstrated to be of no biological relevance. No evidence of
treatment related adverse effects was observed in rats consuming
diets containing meal and oil processed from either 73496 or
73496GLY canola. These results are similar to those of prior studies
reporting no adverse effects in thirteen week rat feeding studies
with GM maize grain and processed fractions from GM soybeans
(Hammond et al., 2006a,b, 2004; MacKenzie et al., 2007; Malley
et al., 2007; Appenzeller et al., 2008, 2009; He et al., 2008; Healy
et al., 2008). In addition to the agronomic comparison and compo-
sitional analysis performed as part of the safety assessment for
new agricultural crops produced using biotechnology (data not
shown), these results support the conclusion that 73496 canola isas safe as its closest non-GM comparator with a history of safe
use (FAO, 2008).5. Conclusions
The results reported in this paper support the conclusion that
food and feed fractions processed from seed of 73496 canola are
as safe and nutritious as the same food and feed fractions pro-
cessed from seed of non-GM canola.Conﬂict of Interest
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